Inventor · disambiguated record
Shuhao Shi
Also filed as: SHI SHUHAO
7 granted patents·4 pending applications·17 citations·filing 2006–2022
77Inventor score
Top patents by PatentIndex Score
11 records- 0184US7273882B2Aminoacetamide acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 25, 2007·7 cites·7 claims
- 0283US7390925B2Oxime-containing acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 24, 2008·5 cites·9 claims
- 0382US7408071B2N-aryl pyrrolidine derivatives as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 5, 2008·4 cites·7 claims
- 0466US8362004B2Piperazine analogs as broad-spectrum influenza antiviralsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 29, 2013·1 cites·28 claims
- 0555US7678784B2Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 16, 2010·0 cites·8 claims
- 0654US7732434B2Macrocyclic acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 8, 2010·0 cites·5 claims
- 0747US7612069B2Acyl guanidines as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 3, 2009·0 cites·11 claims
- 0845US2024277747A1Compounds for Treating Genetic DiseasesZIKANI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0937US2014011700A1Three-dimensional structure of h1n1 nucleoprotein in complex with antiviral compoundsBALDWIN ERIC T·Filed 2012·Application pending·0 cites
- 1036US2012245176A1Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antiviralsCIANCI CHRISTOPHER W·Filed 2011·Application pending·0 cites
- 1132US2022177508A1C10-Cyclic Substituted 13-Membered Macrolides and Uses ThereofZIKANI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuhao Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →